Function/optimization of a nematicidal Cry toxin arsenal

杀线虫 Cry 毒素库的功能/优化

基本信息

  • 批准号:
    7341087
  • 负责人:
  • 金额:
    $ 32.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-04-01 至 2009-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by the applicant): Bacillus thuringiensis (Bt) crystal (Cry) proteins have been used for decades to kill insect pests, including mosquitoes and black flies that transmit human diseases. Cry proteins related to those that kill insects have now been discovered to kill nematodes, although they are not currently used for nematode control. Cry proteins are non-toxic to mammals, making them excellent choices as insecticides and potentially as nematicides. Nematicidal Cry proteins intoxicate a wide range of nematodes, including C. elegans and two mammalian parasitic nematodes that infect the intestine. Intestinal nematodes infect over 1/4 of the human population making them an important medical target for Cry proteins. This application proposes to take advantage of the excellent tools available with C. elegans to study in depth how Cry proteins function, how resistance to Cry proteins develop (an important question even for insects), and, for the first time, address whether Cry proteins have utility in controlling mammalian parasitic nematodes. Variants of one Cry protein with better toxicity towards nematodes will be evolved and then tested for altered functions to correlate structure of toxin with function of toxin (Specific Aim I). This application also proposes to explore the mechanism of resistance to a different nematicidal Cry protein in C. elegans and determine whether this nematicidal protein may be an excellent companion therapeutic for other Cry proteins (Specific Aim II). The information and Cry protein variants generated and studied in Specific Aims I and II will then be applied towards therapy of mammalian parasites. Cry proteins, wild type and improved variants, will be orally administered to rodents infected with intestinal parasites (including one that can infect humans) to optimize therapeutic regimens and to determine which Cry proteins can have a therapeutic effect against the nematodes. The goal of these trials is to lay a foundation for future human studies.
描述(由申请人提供):几十年来,苏云金芽孢杆菌(Bt)晶体(Cry)蛋白一直被用于杀死害虫,包括传播人类疾病的蚊子和黑蝇。与杀死昆虫的那些蛋白相关的CORT蛋白现在被发现可以杀死线虫,尽管它们目前还没有用于线虫控制。CRY蛋白对哺乳动物无毒,这使它们成为杀虫剂和潜在的杀线虫剂的绝佳选择。杀线虫Cry蛋白可毒害多种线虫,包括线虫和两种感染肠道的哺乳动物寄生线虫。肠道线虫感染了超过四分之一的人类种群,使它们成为Cry蛋白的重要药物靶标。这项应用建议利用线虫可用的优秀工具来深入研究Cry蛋白是如何发挥作用的,对Cry蛋白的抗性是如何产生的(即使对昆虫来说也是一个重要的问题),并首次解决Cry蛋白是否有助于控制哺乳动物寄生线虫。对线虫具有更好毒性的一种Cry蛋白的变体将被进化,然后测试其改变的功能,以将毒素的结构与毒素的功能相关联(特定目标I)。本申请还建议探索线虫对一种不同的杀线虫Cry蛋白的抗性机制,并确定该杀线虫蛋白是否可能是其他Cry蛋白的优秀伴生治疗(特异性目标II)。然后,在特定目标I和II中产生和研究的信息和Cry蛋白变体将被应用于哺乳动物寄生虫的治疗。野生型和改良变种的Cry蛋白将被口服给感染肠道寄生虫(包括一种可以感染人类的寄生虫)的啮齿动物,以优化治疗方案,并确定哪些Cry蛋白可以对线虫具有治疗效果。这些试验的目标是为未来的人体研究奠定基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RAFFI V AROIAN其他文献

RAFFI V AROIAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RAFFI V AROIAN', 18)}}的其他基金

Automated high throughput compound screening for broadly active anti-parasitic nematode drugs
自动化高通量化合物筛选广泛活性的抗寄生虫线虫药物
  • 批准号:
    10089408
  • 财政年份:
    2020
  • 资助金额:
    $ 32.64万
  • 项目类别:
Tapping into an anthelmintic Bacillus thuringiensis crystal protein arsenal for human strongyloidiasis
利用苏云金芽孢杆菌晶体蛋白库治疗人类类圆线虫病
  • 批准号:
    10088404
  • 财政年份:
    2020
  • 资助金额:
    $ 32.64万
  • 项目类别:
Automated high throughput compound screening for broadly active anti-parasitic nematode drugs
自动化高通量化合物筛选广泛活性的抗寄生虫线虫药物
  • 批准号:
    10590600
  • 财政年份:
    2020
  • 资助金额:
    $ 32.64万
  • 项目类别:
Automated high throughput compound screening for broadly active anti-parasitic nematode drugs
自动化高通量化合物筛选广泛活性的抗寄生虫线虫药物
  • 批准号:
    10328540
  • 财政年份:
    2020
  • 资助金额:
    $ 32.64万
  • 项目类别:
A dual-purpose vaccine targeting blood-feeding nematode parasites of sheep and humans
针对羊和人类吸血线虫寄生虫的双用途疫苗
  • 批准号:
    10434691
  • 财政年份:
    2019
  • 资助金额:
    $ 32.64万
  • 项目类别:
A dual-purpose vaccine targeting blood-feeding nematode parasites of sheep and humans
针对羊和人类吸血线虫寄生虫的双用途疫苗
  • 批准号:
    9795199
  • 财政年份:
    2019
  • 资助金额:
    $ 32.64万
  • 项目类别:
A dual-purpose vaccine targeting blood-feeding nematode parasites of sheep and humans
针对羊和人类吸血线虫寄生虫的双用途疫苗
  • 批准号:
    10006858
  • 财政年份:
    2019
  • 资助金额:
    $ 32.64万
  • 项目类别:
A dual-purpose vaccine targeting blood-feeding nematode parasites of sheep and humans
针对羊和人类吸血线虫寄生虫的双用途疫苗
  • 批准号:
    10192776
  • 财政年份:
    2019
  • 资助金额:
    $ 32.64万
  • 项目类别:
A dual-purpose vaccine targeting blood-feeding nematode parasites of sheep and humans
针对羊和人类吸血线虫寄生虫的双用途疫苗
  • 批准号:
    10651707
  • 财政年份:
    2019
  • 资助金额:
    $ 32.64万
  • 项目类别:
Harnessing Transcriptomics to Identify and Test Novel Hookworm Vaccine Targets
利用转录组学来识别和测试新型钩虫疫苗靶标
  • 批准号:
    9063524
  • 财政年份:
    2015
  • 资助金额:
    $ 32.64万
  • 项目类别:

相似海外基金

Biosynthesis of bet-alanine in autolysosomes.
自溶酶体中 β-丙氨酸的生物合成。
  • 批准号:
    22K08681
  • 财政年份:
    2022
  • 资助金额:
    $ 32.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding the metabolic consequences of the systemic alanine depletion in pancreatic ductal adenocarcinoma
了解胰腺导管腺癌中全身丙氨酸消耗的代谢后果
  • 批准号:
    474506
  • 财政年份:
    2022
  • 资助金额:
    $ 32.64万
  • 项目类别:
    Studentship Programs
Characterizing alanine transporters as therapeutic targets for pancreatic cancer
将丙氨酸转运蛋白描述为胰腺癌的治疗靶点
  • 批准号:
    466496
  • 财政年份:
    2021
  • 资助金额:
    $ 32.64万
  • 项目类别:
    Studentship Programs
Understanding the requirements of alanine supply and demand in pancreatic ductal adenocarcinoma
了解胰腺导管腺癌中丙氨酸的供需要求
  • 批准号:
    451838
  • 财政年份:
    2021
  • 资助金额:
    $ 32.64万
  • 项目类别:
    Operating Grants
Sensing living P. aeruginosa using D-alanine derived radiotracers
使用 D-丙氨酸衍生的放射性示踪剂感测活的铜绿假单胞菌
  • 批准号:
    10230924
  • 财政年份:
    2021
  • 资助金额:
    $ 32.64万
  • 项目类别:
Sensing living P. aeruginosa using D-alanine derived radiotracers
使用 D-丙氨酸衍生的放射性示踪剂感测活的铜绿假单胞菌
  • 批准号:
    10399593
  • 财政年份:
    2021
  • 资助金额:
    $ 32.64万
  • 项目类别:
Sensing living P. aeruginosa using D-alanine derived radiotracers
使用 D-丙氨酸衍生的放射性示踪剂感测活的铜绿假单胞菌
  • 批准号:
    10570987
  • 财政年份:
    2021
  • 资助金额:
    $ 32.64万
  • 项目类别:
Spot measurement of alanine radicals produced by irradiation and application of sugar radial to dosimeter
辐照产生的丙氨酸自由基的点测及糖自由基在剂量计中的应用
  • 批准号:
    19K05343
  • 财政年份:
    2019
  • 资助金额:
    $ 32.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Metabolic significance of lysosomal beta-alanine
溶酶体β-丙氨酸的代谢意义
  • 批准号:
    18K08528
  • 财政年份:
    2018
  • 资助金额:
    $ 32.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of dosimetry technique for IMRT using alanine dosimeter
使用丙氨酸剂量计开发 IMRT 剂量测定技术
  • 批准号:
    18K15615
  • 财政年份:
    2018
  • 资助金额:
    $ 32.64万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了